Clinical Trials for Malignant Melanoma

Find clinical trials for malignant melanoma. Discover research opportunities and treatment options in your area.

32 Active Trials Found

Showing 32 trials on this page

Page 2 of 2

AMT-253 in Patients With Advanced Solid Tumours

NCT ID: NCT06209580

This clinical trial, called AMT-253, is exploring a new treatment for patients with advanced solid tumors, specifically malignant melanoma that cannot be surgically removed or has spread to other p...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China, Beijing, , China +1 more

Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery

NCT ID: NCT04879654

This clinical trial is studying the use of a medication called Toripalimab, which is designed to help the immune system fight cancer, in combination with radiotherapy (a type of treatment that uses...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy

NCT ID: NCT06294379

This clinical trial is studying a tool called "The Decision Helper," designed to help patients with malignant melanoma make informed choices about their treatment. The goal is to see if this tool i...

Recruiting

Type: observational Locations: Odense C, , Denmark

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT ID: NCT04282044

This clinical trial is investigating a new treatment called CRX100, both on its own and in combination with another drug called Pembrolizumab, for patients with advanced solid tumors. The study aim...

Recruiting

Phase: PHASE1 Type: interventional Locations: Stanford, California, United States, La Jolla, California, United States +1 more

FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis

NCT ID: NCT06206707

This clinical trial is looking at a new treatment option for patients who are experiencing diarrhea and colitis (inflammation of the colon) as a side effect from cancer treatments known as immune c...

Recruiting

Phase: NA Type: interventional Locations: Aarhus N, , Denmark

Melanoma Metastasized to the Brain and Steroids

NCT ID: NCT03563729

This clinical trial is investigating the best treatment options for patients with malignant melanoma that has spread to the brain and who need steroid treatment. Researchers want to see if using a ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Herlev, Hovedstaden, Denmark, Aarhus, Midt, Denmark +1 more

First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

NCT ID: NCT04763083

This clinical trial is testing a new treatment called NVG-111 for patients with certain types of blood cancers and solid tumors. NVG-111 is a special kind of drug designed to help the immune system...

Recruiting

Phase: PHASE1 Type: interventional Locations: London, , United Kingdom, London, , United Kingdom +1 more

Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma

NCT ID: NCT05304546

This clinical trial is designed to investigate new treatment options for patients with advanced melanoma, specifically those with a BRAF V600E/K mutation who have not responded to standard immunoth...

Not yet recruiting

Phase: PHASE2 Type: interventional

Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma

NCT ID: NCT05664139

This clinical trial is investigating a new treatment approach for patients with liver metastases caused by malignant melanoma, a type of skin cancer. The researchers are studying the use of a speci...

Not yet recruiting

Phase: PHASE2 Type: interventional

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

NCT ID: NCT05037825

This clinical trial is exploring the relationship between the gut microbiome and how well certain cancer treatments work, specifically immunotherapy for cancers like lung cancer, melanoma, breast c...

Recruiting

Type: observational Locations: Elizabethtown, Kentucky, United States

A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma

NCT ID: NCT04126876

This clinical trial is studying a new treatment called IMO-2125 for patients with a specific type of skin cancer known as malignant melanoma. The trial is aimed at people who have a more advanced s...

Recruiting

Phase: PHASE2 Type: interventional Locations: Amsterdam, , Netherlands

Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma

NCT ID: NCT02673970

This clinical trial is looking at how certain biological markers can help understand the effectiveness of a type of treatment called immune checkpoint inhibitors (ICIs) in patients with advanced me...

Recruiting

Type: observational Locations: Jette, Brabant, Belgium

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions